Lukas C. Bal studied medicine at the University Medical Centre Hamburg-Eppendorf (UKE) and completed clinical internships in Vienna, the University Hospital Heidelberg, University Hospital Rechts der Isar (Munich), and the National Hospital for Neurology and Neurosurgery (London, UK). He also studied neurodegenerative diseases at Yale Medical School in the Lab of Prof. Strittmatter (New Haven, USA). Conducting his MD thesis at the INIMS (Hamburg, Germany), he explored how inflammatory neuronal stress leads to elevated VGF levels and its influence on neuronal demise in multiple sclerosis. In August 2023, he began his residency at the Department of Neurology at the University Medical Center Hamburg-Eppendorf (UKE). Continuing his research at the INIMS, he is dedicated to identifying novel therapeutic approaches for mitigating neurodegeneration in multiple sclerosis. During his studies, he received scholarships from the German Academic Scholarship Foundation, the Hertie Foundation, and funding from the excellence initiative of the University of Hamburg for student research groups.
Link to Pubmed